Search - tctmd.com

Displaying 841 - 860 of 4702

Sort: Relevancy | Date

Presentation NY Valves 2024

The Future is Now! TAVR is a Favorable Alternative in AS Patients Under 65 Years Old

Presenter: Bernard Prendergast

June 06, 2024

Presentation NY Valves 2024

Use of VA ECMO for TAVR in a High Risk Patient After Cardiac Arrest

Presenter: Badri Aryal

June 06, 2024

Presentation NY Valves 2024

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

Presenter: Keith B. Allen

June 06, 2024

Presentation NY Valves 2024

TAVR in Young Patients - Current Treatment Patterns in the US

Presenter: Mayra Guerrero

June 06, 2024

Presentation NY Valves 2024

Hybrid VIV TAVR With Open Leaflet Excision to Avoid Coronary Obstruction: The Heart Team Approach

Presenter: Sankalp P. Patel

June 06, 2024

Presentation NY Valves 2024

Balloon Expandable Valve-in-Valve TAVR With Coronary Protection

Presenter: Konstantinos Voudris

June 06, 2024

Presentation NY Valves 2024

Aortic Valve Replacement in BAV: Biprosthesis for Everyone? When to Consider TAVR? Do We Need Thoughtful RCTs?

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

LM Protection in an Intra-Annular Self-Expanding Valve

Presenter: Rajeev Samtani

June 06, 2024

Presentation NY Valves 2024

Periprocedural Echocardiography Is Critical for the Success of Transcatheter Aortic Valve Replacement

Presenter: Francesca Romana Prandi

June 06, 2024

Presentation NY Valves 2024

Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning

Presenter: Vinayak N. Bapat

June 06, 2024

Presentation NY Valves 2024

Mind Your Stent: Managing Ostial Right Coronary Artery Stent Protrusion Before TAVR

Presenter: Ahmed Hassanin

June 06, 2024

Presentation NY Valves 2024

Ping-Pong Technique to Avoid Left Main Occlusion During TAVI

Presenter: Vincenzo Cesario

June 06, 2024

Presentation NY Valves 2024

In younger patients receiving TAVR: why does the first intervention matter?

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Presenter: David J. Cohen

June 06, 2024

Presentation NY Valves 2024

Which endpoints and definitions matter for assessment of bioprosthetic valve durability following TAVR?

Presenter: Philippe Pibarot

June 06, 2024

Presentation NY Valves 2024

Tips and Tricks for TAVR Explantation

Presenter: Vinayak N. Bapat

June 06, 2024

Presentation NY Valves 2024

SAVR After TAVR: A Dangerous Epidemic?

Presenter: Shinichi Fukuhara

June 06, 2024

Presentation NY Valves 2024

Redo TAVR Through Embolized Evolut FX Valve

Presenter: Richard Tanner

June 06, 2024

Presentation NY Valves 2024

TAVR-in-TAVR for an Early Degenerated Bio-Prosthesis

Presenter: Vivek Patel

June 06, 2024

Advertisement

The Future is Now! TAVR is a Favorable Alternative in AS Patients Under 65 Years Old

Use of VA ECMO for TAVR in a High Risk Patient After Cardiac Arrest

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

TAVR in Young Patients - Current Treatment Patterns in the US

Hybrid VIV TAVR With Open Leaflet Excision to Avoid Coronary Obstruction: The Heart Team Approach

Balloon Expandable Valve-in-Valve TAVR With Coronary Protection

Aortic Valve Replacement in BAV: Biprosthesis for Everyone? When to Consider TAVR? Do We Need Thoughtful RCTs?

LM Protection in an Intra-Annular Self-Expanding Valve

Periprocedural Echocardiography Is Critical for the Success of Transcatheter Aortic Valve Replacement

Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning

Mind Your Stent: Managing Ostial Right Coronary Artery Stent Protrusion Before TAVR

Ping-Pong Technique to Avoid Left Main Occlusion During TAVI

In younger patients receiving TAVR: why does the first intervention matter?

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Which endpoints and definitions matter for assessment of bioprosthetic valve durability following TAVR?

Tips and Tricks for TAVR Explantation

SAVR After TAVR: A Dangerous Epidemic?

Redo TAVR Through Embolized Evolut FX Valve

TAVR-in-TAVR for an Early Degenerated Bio-Prosthesis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content